ArticleAAPS PharmSciTech2025
Tabletability Enhancement of Acetaminophen Coated with a Nanocellulose Suspension using a Fluidized Bed.
Article in AAPS PharmSciTech, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fluidized bed coating was investigated as a method to coat aqueous suspensions of nanocellulose onto acetaminophen (APAP) for the purpose of tabletability enhancement. Effects of suspension concentration and fluidized bed processing conditions were evaluated. Nanocellulose coatings of up to 2.0% w/w were achieved. This study found that the nanocellulose coating significantly improved the tabletability of APAP. A 2.0% w/w coating increased tablet tensile strength by nearly 200%. With respect to tablet formulation, it was found that APAP coated with 2.0% w/w nanocellulose allowed a 60% reduction in filler to produce tablets acceptable for manufacturing compared to APAP without nanocellulose. The effectiveness of fluidized bed coating was also compared to a twin-screw extrusion process which was previously used to coat nanocellulose onto APAP. It was concluded that process conditions and the process method had no effect on the extent of tabletability enhancement provided by nanocellulose. Improvement to tabletability was only dependent on the concentration of nanocellulose coated. Fluidized bed coating may be more advantageous than twin-screw processing due to the inherent ability of the former to better control liquid addition and removal. Accordingly, fluidized bed coating was able to achieve a higher coating concentration than the twin-screw process. Overall, the use of small amounts of nanocellulose to substantially improve tabletability of APAP and to reduce the need for filler excipients is evident.
Indexed as
Identifiers
40855380What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.